Skip to content
2000
Volume 25, Issue 5
  • ISSN: 1568-0096
  • E-ISSN: 1873-5576

Abstract

Background

TMEM189 is a recently discovered transmembrane protein involved in ether glycerophospholipid synthesis and ferroptosis regulation. However, its role in tumors is not well understood.

Objective

This study aimed to elucidate the oncogenic effects and prognostic values of TMEM189 in tumors.

Methods

We performed a pan-cancer analysis of TMEM189 using various databases, bioinformatics and statistical tools, and tissue microarray analysis.

Results

TMEM189 was upregulated in tumors compared to normal tissues. High TMEM189 expression was found to be linked to reduced promoter methylation. Moreover, TMEM189 exhibited a negative correlation with immunogenic markers, immune cell infiltration, and expression of Immune Checkpoint Genes (ICGs) in most cancers, implicating its immunosuppressive role in tumor microenvironments (TME). The genes that interact and are similar to TMEM189 were involved in hotspot signaling pathways in pan-cancer. TMEM189 overexpression was found to be usually associated with poor prognosis, especially an independent prognostic risk factor for BLCA, BRCA, LUAD, MESO, LIHC, and SKCM.

Conclusion

TMEM189 is overexpressed and exerts immunosuppressive effects in many tumors with a significant association with poor prognosis, suggesting its potential as a therapeutic target in cancer treatment.

Loading

Article metrics loading...

/content/journals/ccdt/10.2174/0115680096308701240605114342
2024-06-26
2025-04-21
Loading full text...

Full text loading...

References

  1. StockwellB.R. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications.Cell2022185142401242110.1016/j.cell.2022.06.00335803244
    [Google Scholar]
  2. ChenX. KangR. KroemerG. TangD. Broadening horizons: The role of ferroptosis in cancer.Nat. Rev. Clin. Oncol.202118528029610.1038/s41571‑020‑00462‑033514910
    [Google Scholar]
  3. StockwellB.R. Friedmann AngeliJ.P. BayirH. BushA.I. ConradM. DixonS.J. FuldaS. GascónS. HatziosS.K. KaganV.E. NoelK. JiangX. LinkermannA. MurphyM.E. OverholtzerM. OyagiA. PagnussatG.C. ParkJ. RanQ. RosenfeldC.S. SalnikowK. TangD. TortiF.M. TortiS.V. ToyokuniS. WoerpelK.A. ZhangD.D. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease.Cell2017171227328510.1016/j.cell.2017.09.02128985560
    [Google Scholar]
  4. PerezM.A. ClostioA.J. HoustonI.R. RuizJ. MagtanongL. DixonS.J. WattsJ.L. Ether lipid deficiency disrupts lipid homeostasis leading to ferroptosis sensitivity.PLoS Genet.2022189e101043610.1371/journal.pgen.101043636178986
    [Google Scholar]
  5. KimJ.W. LeeJ.Y. OhM. LeeE.W. An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis.Exp. Mol. Med.20235581620163110.1038/s12276‑023‑01077‑y37612411
    [Google Scholar]
  6. WernerE.R. KellerM.A. SailerS. LacknerK. KochJ. HermannM. CoassinS. GoldererG. Werner-FelmayerG. ZoellerR.A. HuloN. BergerJ. WatschingerK. The TMEM189 gene encodes plasmanylethanolamine desaturase which introduces the characteristic vinyl ether double bond into plasmalogens.Proc. Natl. Acad. Sci.2020117147792779810.1073/pnas.191746111732209662
    [Google Scholar]
  7. Gallego-GarcíaA. Monera-GironaA.J. Pajares-MartínezE. Bastida-MartínezE. Pérez-CastañoR. IniestaA.A. FontesM. PadmanabhanS. Elías-ArnanzM. A bacterial light response reveals an orphan desaturase for human plasmalogen synthesis.Science2019366646112813210.1126/science.aay143631604315
    [Google Scholar]
  8. PadmanabhanS. Monera-GironaA.J. Pajares-MartínezE. Bastida-MartínezE. del Rey NavalónI. Pérez-CastañoR. Galbis-MartínezM.L. FontesM. Elías-ArnanzM. Plasmalogens and photooxidative stress signaling in myxobacteria, and how it unmasked CarF/TMEM189 as the Δ1′-Desaturase PEDS1 for human plasmalogen biosynthesis.Front. Cell Dev. Biol.20221088468910.3389/fcell.2022.88468935646900
    [Google Scholar]
  9. CuiW. LiuD. GuW. ChuB. Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis.Cell Death Differ.20212882536255110.1038/s41418‑021‑00769‑033731874
    [Google Scholar]
  10. YuJ. QuL. XiaY. ZhangX. FengJ. DuanM. guoP. LouY. LvP. LuW. ChenY. TMEM189 negatively regulates the stability of ULK1 protein and cell autophagy.Cell Death Dis.202213431610.1038/s41419‑022‑04722‑y35393404
    [Google Scholar]
  11. LiuJ. SunM. SunY. LiH. TMEM189 promotes breast cancer through inhibition of autophagy-regulated ferroptosis.Biochem. Biophys. Res. Commun.2022622374410.1016/j.bbrc.2022.06.02435843092
    [Google Scholar]
  12. FanD. MaY. QiY. YangX. ZhaoH. TMEM189 as a target gene of MiR-499a-5p regulates breast cancer progression through the ferroptosis pathway.J. Clin. Biochem. Nutr.202373215416010.3164/jcbn.22‑13037700851
    [Google Scholar]
  13. PapinM. FontaineD. GoupilleC. FigielS. DomingoI. PinaultM. GuimaraesC. GuyonN. CartronP.F. EmondP. LefevreA. GueguinouM. CrottèsD. JaffrèsP.A. OuldamerL. MaheoK. FromontG. Potier-CartereauM. BougnouxP. ChantômeA. VandierC. Endogenous ether-lipids differentially promote tumour aggressiveness by regulating the SK3 channel.J. Lipid Res.202410054410054410.1016/j.jlr.2024.10054438642894
    [Google Scholar]
  14. LiT. FuJ. ZengZ. CohenD. LiJ. ChenQ. LiB. LiuX.S. TIMER2.0 for analysis of tumor-infiltrating immune cells.Nucleic Acids Res.202048W1W509W51410.1093/nar/gkaa40732442275
    [Google Scholar]
  15. TangZ. KangB. LiC. ChenT. ZhangZ. GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis.Nucleic Acids Res.201947W1W556W56010.1093/nar/gkz43031114875
    [Google Scholar]
  16. ChandrashekarD.S. BashelB. BalasubramanyaS.A.H. CreightonC.J. Ponce-RodriguezI. ChakravarthiB.V.S.K. VaramballyS. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses.Neoplasia201719864965810.1016/j.neo.2017.05.00228732212
    [Google Scholar]
  17. ChenF. ChandrashekarD.S. VaramballyS. CreightonC.J. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers.Nat. Commun.2019101567910.1038/s41467‑019‑13528‑031831737
    [Google Scholar]
  18. LinJ. JiA. QiuG. FengH. LiJ. LiS. ZouY. CuiY. SongC. HeH. LuY. FBW 7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.Cancer Sci.201810941001101110.1111/cas.1352829427543
    [Google Scholar]
  19. CeramiE. GaoJ. DogrusozU. GrossB.E. SumerS.O. AksoyB.A. JacobsenA. ByrneC.J. HeuerM.L. LarssonE. AntipinY. RevaB. GoldbergA.P. SanderC. SchultzN. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data.Cancer Discov.20122540140410.1158/2159‑8290.CD‑12‑009522588877
    [Google Scholar]
  20. BarbieD.A. TamayoP. BoehmJ.S. KimS.Y. MoodyS.E. DunnI.F. SchinzelA.C. SandyP. MeylanE. SchollC. FröhlingS. ChanE.M. SosM.L. MichelK. MermelC. SilverS.J. WeirB.A. ReilingJ.H. ShengQ. GuptaP.B. WadlowR.C. LeH. HoerschS. WittnerB.S. RamaswamyS. LivingstonD.M. SabatiniD.M. MeyersonM. ThomasR.K. LanderE.S. MesirovJ.P. RootD.E. GillilandD.G. JacksT. HahnW.C. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.Nature2009462726910811210.1038/nature0846019847166
    [Google Scholar]
  21. JiangP. GuS. PanD. FuJ. SahuA. HuX. LiZ. TraughN. BuX. LiB. LiuJ. FreemanG.J. BrownM.A. WucherpfennigK.W. LiuX.S. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.Nat. Med.201824101550155810.1038/s41591‑018‑0136‑130127393
    [Google Scholar]
  22. YoshiharaK. ShahmoradgoliM. MartínezE. VegesnaR. KimH. Torres-GarciaW. TreviñoV. ShenH. LairdP.W. LevineD.A. CarterS.L. GetzG. Stemke-HaleK. MillsG.B. VerhaakR.G.W. Inferring tumour purity and stromal and immune cell admixture from expression data.Nat. Commun.201341261210.1038/ncomms361224113773
    [Google Scholar]
  23. SzklarczykD. GableA.L. LyonD. JungeA. WyderS. Huerta-CepasJ. SimonovicM. DonchevaN.T. MorrisJ.H. BorkP. JensenL.J. MeringC. STRING v11: Protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.Nucleic Acids Res.201947D1D607D61310.1093/nar/gky113130476243
    [Google Scholar]
  24. ShannonP. MarkielA. OzierO. BaligaN.S. WangJ.T. RamageD. AminN. SchwikowskiB. IdekerT. Cytoscape: A software environment for integrated models of biomolecular interaction networks.Genome Res.200313112498250410.1101/gr.123930314597658
    [Google Scholar]
  25. ZhouY. ZhouB. PacheL. ChangM. KhodabakhshiA.H. TanaseichukO. BennerC. ChandaS.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Nat. Commun.2019101152310.1038/s41467‑019‑09234‑630944313
    [Google Scholar]
  26. IasonosA. SchragD. RajG.V. PanageasK.S. How to build and interpret a nomogram for cancer prognosis.J. Clin. Oncol.20082681364137010.1200/JCO.2007.12.979118323559
    [Google Scholar]
  27. LitchfieldK. ReadingJ.L. PuttickC. ThakkarK. AbboshC. BenthamR. WatkinsT.B.K. RosenthalR. BiswasD. RowanA. LimE. Al BakirM. TuratiV. Guerra-AssunçãoJ.A. CondeL. FurnessA.J.S. SainiS.K. HadrupS.R. HerreroJ. LeeS.H. Van LooP. EnverT. LarkinJ. HellmannM.D. TurajlicS. QuezadaS.A. McGranahanN. SwantonC. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition.Cell20211843596614.e1410.1016/j.cell.2021.01.00233508232
    [Google Scholar]
  28. LeD.T. DurhamJ.N. SmithK.N. WangH. BartlettB.R. AulakhL.K. LuS. KemberlingH. WiltC. LuberB.S. WongF. AzadN.S. RuckiA.A. LaheruD. DonehowerR. ZaheerA. FisherG.A. CrocenziT.S. LeeJ.J. GretenT.F. DuffyA.G. CiomborK.K. EyringA.D. LamB.H. JoeA. KangS.P. HoldhoffM. DanilovaL. CopeL. MeyerC. ZhouS. GoldbergR.M. ArmstrongD.K. BeverK.M. FaderA.N. TaubeJ. HousseauF. SpetzlerD. XiaoN. PardollD.M. PapadopoulosN. KinzlerK.W. EshlemanJ.R. VogelsteinB. AndersR.A. DiazL.A.Jr Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.Science2017357634940941310.1126/science.aan673328596308
    [Google Scholar]
  29. DingL. ChenF. Predicting tumor response to PD-1 blockade.N. Engl. J. Med.2019381547747910.1056/NEJMcibr190634031365807
    [Google Scholar]
  30. SteeleC.D. AbbasiA. IslamS.M.A. BowesA.L. KhandekarA. HaaseK. Hames-FathiS. AjayiD. VerfaillieA. DhamiP. McLatchieA. LechnerM. LightN. ShlienA. MalkinD. FeberA. ProszekP. LesluyesT. MertensF. FlanaganA.M. TarabichiM. Van LooP. AlexandrovL.B. PillayN. Signatures of copy number alterations in human cancer.Nature2022606791698499110.1038/s41586‑022‑04738‑635705804
    [Google Scholar]
  31. SmithJ. SenS. WeeksR.J. EcclesM.R. ChatterjeeA. Promoter DNA hypermethylation and paradoxical gene activation.Trends Cancer20206539240610.1016/j.trecan.2020.02.00732348735
    [Google Scholar]
  32. KalbasiA. RibasA. Tumour-intrinsic resistance to immune checkpoint blockade.Nat. Rev. Immunol.2020201253910.1038/s41577‑019‑0218‑431570880
    [Google Scholar]
  33. TengM.W.L. NgiowS.F. RibasA. SmythM.J. Classifying cancers based on T-cell infiltration and PD-L1.Cancer Res.201575112139214510.1158/0008‑5472.CAN‑15‑025525977340
    [Google Scholar]
  34. PicardaE. OhaegbulamK.C. ZangX. Molecular Pathways: Targeting B7-H3 (CD276) for human cancer immunotherapy.Clin. Cancer Res.201622143425343110.1158/1078‑0432.CCR‑15‑242827208063
    [Google Scholar]
  35. ThorssonV. GibbsD.L. BrownS.D. WolfD. BortoneD.S. Ou YangT.H. Porta-PardoE. GaoG.F. PlaisierC.L. EddyJ.A. ZivE. CulhaneA.C. PaullE.O. SivakumarI.K.A. GentlesA.J. MalhotraR. FarshidfarF. ColapricoA. ParkerJ.S. MoseL.E. VoN.S. LiuJ. LiuY. RaderJ. DhankaniV. ReynoldsS.M. BowlbyR. CalifanoA. CherniackA.D. AnastassiouD. BedognettiD. MokrabY. NewmanA.M. RaoA. ChenK. KrasnitzA. HuH. MaltaT.M. NoushmehrH. PedamalluC.S. BullmanS. OjesinaA.I. LambA. ZhouW. ShenH. ChoueiriT.K. WeinsteinJ.N. GuinneyJ. SaltzJ. HoltR.A. RabkinC.S. LazarA.J. SerodyJ.S. DemiccoE.G. DisisM.L. VincentB.G. ShmulevichI. Caesar-JohnsonS.J. DemchokJ.A. FelauI. KasapiM. FergusonM.L. HutterC.M. SofiaH.J. TarnuzzerR. WangZ. YangL. ZenklusenJ.C. ZhangJ.J. ChudamaniS. LiuJ. LollaL. NareshR. PihlT. SunQ. WanY. WuY. ChoJ. DeFreitasT. FrazerS. GehlenborgN. GetzG. HeimanD.I. KimJ. LawrenceM.S. LinP. MeierS. NobleM.S. SaksenaG. VoetD. ZhangH. BernardB. ChambweN. DhankaniV. KnijnenburgT. KramerR. LeinonenK. LiuY. MillerM. ReynoldsS. ShmulevichI. ThorssonV. ZhangW. AkbaniR. BroomB.M. HegdeA.M. JuZ. KanchiR.S. KorkutA. LiJ. LiangH. LingS. LiuW. LuY. MillsG.B. NgK-S. RaoA. RyanM. WangJ. WeinsteinJ.N. ZhangJ. AbeshouseA. ArmeniaJ. ChakravartyD. ChatilaW.K. de BruijnI. GaoJ. GrossB.E. HeinsZ.J. KundraR. LaK. LadanyiM. LunaA. NissanM.G. OchoaA. PhillipsS.M. ReznikE. Sanchez-VegaF. SanderC. SchultzN. SheridanR. SumerS.O. SunY. TaylorB.S. WangJ. ZhangH. AnurP. PetoM. SpellmanP. BenzC. StuartJ.M. WongC.K. YauC. HayesD.N. ParkerJ.S. WilkersonM.D. AllyA. BalasundaramM. BowlbyR. BrooksD. CarlsenR. ChuahE. DhallaN. HoltR. JonesS.J.M. KasaianK. LeeD. MaY. MarraM.A. MayoM. MooreR.A. MungallA.J. MungallK. RobertsonA.G. SadeghiS. ScheinJ.E. SipahimalaniP. TamA. ThiessenN. TseK. WongT. BergerA.C. BeroukhimR. CherniackA.D. CibulskisC. GabrielS.B. GaoG.F. HaG. MeyersonM. SchumacherS.E. ShihJ. KucherlapatiM.H. KucherlapatiR.S. BaylinS. CopeL. DanilovaL. BootwallaM.S. LaiP.H. MaglinteD.T. Van Den BergD.J. WeisenbergerD.J. AumanJ.T. BaluS. BodenheimerT. FanC. HoadleyK.A. HoyleA.P. JefferysS.R. JonesC.D. MengS. MieczkowskiP.A. MoseL.E. PerouA.H. PerouC.M. RoachJ. ShiY. SimonsJ.V. SkellyT. SolowayM.G. TanD. VeluvoluU. FanH. HinoueT. LairdP.W. ShenH. ZhouW. BellairM. ChangK. CovingtonK. CreightonC.J. DinhH. DoddapaneniH.V. DonehowerL.A. DrummondJ. GibbsR.A. GlennR. HaleW. HanY. HuJ. KorchinaV. LeeS. LewisL. LiW. LiuX. MorganM. MortonD. MuznyD. SantibanezJ. ShethM. ShinbrotE. WangL. WangM. WheelerD.A. XiL. ZhaoF. HessJ. AppelbaumE.L. BaileyM. CordesM.G. DingL. FronickC.C. FultonL.A. FultonR.S. KandothC. MardisE.R. McLellanM.D. MillerC.A. SchmidtH.K. WilsonR.K. CrainD. CurleyE. GardnerJ. LauK. MalleryD. MorrisS. PaulauskisJ. PennyR. SheltonC. SheltonT. ShermanM. ThompsonE. YenaP. BowenJ. Gastier-FosterJ.M. GerkenM. LeraasK.M. LichtenbergT.M. RamirezN.C. WiseL. ZmudaE. CorcoranN. CostelloT. HovensC. CarvalhoA.L. de CarvalhoA.C. FregnaniJ.H. Longatto-FilhoA. ReisR.M. Scapulatempo-NetoC. SilveiraH.C.S. VidalD.O. BurnetteA. EschbacherJ. HermesB. NossA. SinghR. AndersonM.L. CastroP.D. IttmannM. HuntsmanD. KohlB. LeX. ThorpR. AndryC. DuffyE.R. LyadovV. PaklinaO. SetdikovaG. ShabuninA. TavobilovM. McPhersonC. WarnickR. BerkowitzR. CramerD. FeltmateC. HorowitzN. KibelA. MutoM. RautC.P. MalykhA. Barnholtz-SloanJ.S. BarrettW. DevineK. FulopJ. OstromQ.T. ShimmelK. WolinskyY. SloanA.E. De RoseA. GiulianteF. GoodmanM. KarlanB.Y. HagedornC.H. EckmanJ. HarrJ. MyersJ. TuckerK. ZachL.A. DeyarminB. HuH. KvecherL. LarsonC. MuralR.J. SomiariS. VichaA. ZelinkaT. BennettJ. IacoccaM. RabenoB. SwansonP. LatourM. LacombeL. TêtuB. BergeronA. McGrawM. StaugaitisS.M. ChabotJ. HibshooshH. SepulvedaA. SuT. WangT. PotapovaO. VoroninaO. DesjardinsL. MarianiO. Roman-RomanS. SastreX. SternM-H. ChengF. SignorettiS. BerchuckA. BignerD. LippE. MarksJ. McCallS. McLendonR. SecordA. SharpA. BeheraM. BratD.J. ChenA. DelmanK. ForceS. KhuriF. MaglioccaK. MaithelS. OlsonJ.J. OwonikokoT. PickensA. RamalingamS. ShinD.M. SicaG. Van MeirE.G. ZhangH. EijckenboomW. GillisA. KorpershoekE. LooijengaL. OosterhuisW. StoopH. van KesselK.E. ZwarthoffE.C. CalatozzoloC. CuppiniL. CuzzubboS. DiMecoF. FinocchiaroG. MatteiL. PerinA. PolloB. ChenC. HouckJ. LohavanichbutrP. HartmannA. StoehrC. StoehrR. TaubertH. WachS. WullichB. KyclerW. MurawaD. WiznerowiczM. ChungK. EdenfieldW.J. MartinJ. BaudinE. BubleyG. BuenoR. De RienzoA. RichardsW.G. KalkanisS. MikkelsenT. NoushmehrH. ScarpaceL. GirardN. AymerichM. CampoE. GinéE. GuillermoA.L. Van BangN. HanhP.T. PhuB.D. TangY. ColmanH. EvasonK. DottinoP.R. MartignettiJ.A. GabraH. JuhlH. AkeredoluT. StepaS. HoonD. AhnK. KangK.J. BeuschleinF. BreggiaA. BirrerM. BellD. BoradM. BryceA.H. CastleE. ChandanV. ChevilleJ. CoplandJ.A. FarnellM. FlotteT. GiamaN. HoT. KendrickM. KocherJ-P. KoppK. MoserC. NagorneyD. O’BrienD. O’NeillB.P. PatelT. PetersenG. QueF. RiveraM. RobertsL. SmallridgeR. SmyrkT. StantonM. ThompsonR.H. TorbensonM. YangJ.D. ZhangL. BrimoF. AjaniJ.A. GonzalezA.M.A. BehrensC. BondarukJ. BroaddusR. CzerniakB. EsmaeliB. FujimotoJ. GershenwaldJ. GuoC. LazarA.J. LogothetisC. Meric-BernstamF. MoranC. RamondettaL. RiceD. SoodA. TamboliP. ThompsonT. TroncosoP. TsaoA. WistubaI. CarterC. HayduL. HerseyP. JakrotV. KakavandH. KeffordR. LeeK. LongG. MannG. QuinnM. SawR. ScolyerR. ShannonK. SpillaneA. Stretch SynottM. ThompsonJ. WilmottJ. Al-AhmadieH. ChanT.A. GhosseinR. GopalanA. LevineD.A. ReuterV. SingerS. SinghB. TienN.V. BroudyT. MirsaidiC. NairP. DrwiegaP. MillerJ. SmithJ. ZarenH. ParkJ-W. HungN.P. KebebewE. LinehanW.M. MetwalliA.R. PacakK. PintoP.A. SchiffmanM. SchmidtL.S. VockeC.D. WentzensenN. WorrellR. YangH. MoncrieffM. GoparajuC. MelamedJ. PassH. BotnariucN. CaramanI. CernatM. ChemencedjiI. ClipcaA. DorucS. GorincioiG. MuraS. PirtacM. StanculI. TcaciucD. AlbertM. AlexopoulouI. ArnaoutA. BartlettJ. EngelJ. GilbertS. ParfittJ. SekhonH. ThomasG. RasslD.M. RintoulR.C. BifulcoC. TamakawaR. UrbaW. HaywardN. TimmersH. AntenucciA. FaccioloF. GraziG. MarinoM. MerolaR. de KrijgerR. Gimenez-RoqueploA-P. PichéA. ChevalierS. McKercherG. BirsoyK. BarnettG. BrewerC. FarverC. NaskaT. PennellN.A. RaymondD. SchileroC. SmolenskiK. WilliamsF. MorrisonC. BorgiaJ.A. LiptayM.J. PoolM. SederC.W. JunkerK. OmbergL. DinkinM. ManikhasG. AlvaroD. BragazziM.C. CardinaleV. CarpinoG. GaudioE. CheslaD. CottinghamS. DubinaM. MoiseenkoF. DhanasekaranR. BeckerK-F. JanssenK-P. Slotta-HuspeninaJ. Abdel-RahmanM.H. AzizD. BellS. CebullaC.M. DavisA. DuellR. ElderJ.B. HiltyJ. KumarB. LangJ. LehmanN.L. MandtR. NguyenP. PilarskiR. RaiK. SchoenfieldL. SenecalK. WakelyP. HansenP. LechanR. PowersJ. TischlerA. GrizzleW.E. SextonK.C. KastlA. HendersonJ. PortenS. WaldmannJ. FassnachtM. AsaS.L. SchadendorfD. CouceM. GraefenM. HulandH. SauterG. SchlommT. SimonR. TennstedtP. OlabodeO. NelsonM. BatheO. CarrollP.R. ChanJ.M. DisaiaP. GlennP. KelleyR.K. LandenC.N. PhillipsJ. PradosM. SimkoJ. Smith-McCuneK. VandenBergS. RogginK. FehrenbachA. KendlerA. SifriS. SteeleR. JimenoA. CareyF. ForgieI. MannelliM. CarneyM. HernandezB. CamposB. Herold-MendeC. JungkC. UnterbergA. von DeimlingA. BosslerA. GalbraithJ. JacobusL. KnudsonM. KnutsonT. MaD. MilhemM. SigmundR. GodwinA.K. MadanR. RosenthalH.G. AdebamowoC. AdebamowoS.N. BoussioutasA. BeerD. GiordanoT. Mes-MassonA-M. SaadF. BocklageT. LandrumL. MannelR. MooreK. MoxleyK. PostierR. WalkerJ. ZunaR. FeldmanM. ValdiviesoF. DhirR. LuketichJ. PineroE.M.M. Quintero-AguiloM. CarlottiC.G.Jr Dos SantosJ.S. KempR. SankarankutyA. TirapelliD. CattoJ. AgnewK. SwisherE. CreaneyJ. RobinsonB. ShelleyC.S. GodwinE.M. KendallS. ShipmanC. BradfordC. CareyT. HaddadA. MoyerJ. PetersonL. PrinceM. RozekL. WolfG. BowmanR. FongK.M. YangI. KorstR. RathmellW.K. Fantacone-CampbellJ.L. HookeJ.A. KovatichA.J. ShriverC.D. DiPersioJ. DrakeB. GovindanR. HeathS. LeyT. Van TineB. WesterveltP. RubinM.A. LeeJ.I. AredesN.D. MariamidzeA. The immune landscape of cancer.Immunity2018484812830.e1410.1016/j.immuni.2018.03.02329628290
    [Google Scholar]
  36. WuJ. MinikesA.M. GaoM. BianH. LiY. StockwellB.R. ChenZ.N. JiangX. Publisher Correction: Intercellular interaction dictates cancer cell ferroptosis via NF2–YAP signalling.Nature20195727770E2010.1038/s41586‑019‑1480‑031371811
    [Google Scholar]
  37. LuoY. AkatsukaS. MotookaY. KongY. ZhengH. MashimoT. ImaokaT. ToyokuniS. BRCA1 haploinsufficiency impairs iron metabolism to promote chrysotile‐induced mesothelioma via ferroptosis resistance.Cancer Sci.202311441423143610.1111/cas.1570536541514
    [Google Scholar]
  38. LiZ. JiangL. ChewS.H. HirayamaT. SekidoY. ToyokuniS. Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia.Redox Biol.20192610129710.1016/j.redox.2019.10129731442913
    [Google Scholar]
/content/journals/ccdt/10.2174/0115680096308701240605114342
Loading
/content/journals/ccdt/10.2174/0115680096308701240605114342
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s web site along with the published article.


  • Article Type:
    Research Article
Keyword(s): analysis; ferroptosis; immune microenvironment; pan-cancer; prognosis; TMEM189
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test